Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0.
Saved in:
| Title: | Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0. |
|---|---|
| Authors: | Silvestro A; GSK, Waltham, MA., Baden J; Bristol Myers Squibb, Lawrence Township, NJ., Billings K; Streck, La Vista, NE., Bramlett K; Quest Diagnostics, Secaucus, NJ., Corner A; Bio-Rad, Pleasanton, CA., Danek T; Tempus AI, Chicago, IL., Deras I; Formerly with Illumina, San Diego, CA., Dickey J; Labcorp (PGDx), Baltimore, MD., Godsey JH; Formerly with Quest Diagnostics, Secaucus, NJ., Guan L; Illumina, San Diego, CA., Hutchinson T; Freenome, San Francisco, CA., Johann DJ; University of Arkansas, Little Rock, AR., Lee JSH; University of Southern California, Los Angeles, CA., Lin CJ; Freenome, San Francisco, CA., Lococo JS; Illumina, San Diego, CA., Lopez Ramos D; BLOODPAC, Chicago, IL., Richardson AO; Freenome, San Francisco, CA., Stetson D; Astrazeneca, Wilmington, DE., Wenz P; Illumina, San Diego, CA., Leiman LC; BLOODPAC, Chicago, IL. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2026 May; Vol. 10 (5), pp. e2501243. Date of Electronic Publication: 2026 May 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
